- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03712982
Attention to Variability During Infertility
Infertility affects approximately one in seven couples, and it can be a devastating diagnosis and difficult experience for couples to endure. Ellen Langer, Ph.D., Director of the Langer Lab at Harvard, has spent several decades demonstrating evidence supporting a mind-body approach to improve wellbeing and overall functioning. Specifically, she asserts that Mindfulness in its most basic sense - paying attention in the moment - is enough to create both perceived (e.g., self-reported) and real (e.g., objective testing) change. Langer and her colleague, for example, demonstrated that "Trait mindfulness predicted the well-being of expecting mothers and better neonatal outcomes. Mindfulness training resulted in better health for the expecting mother". In this study, Mindfulness training refers to "attention to sensation variability." Such interventions are cost effective, minimally invasive, less time-consuming for practitioners and participants and generally easy to learn.
Langer and her colleague's study refers to pregnancy. Infertility is unlike pregnancy in its exact clinical diagnosis. Nevertheless, similar to pregnancy, infertility is considered a clinical condition affecting the body, in this case the reproductive system. Therefore, based on the results of studies like Langer and her colleague's, that used participants with clinical conditions affecting the reproductive system, the investigators propose similar mindfulness intervention (attention to sensation variability) research with infertile individuals. However, the investigators intend to extend our examination to also include a treatment group with the partners of the infertile individuals, as little, if any research, has attempted to do so previously. The investigators hypothesize that state mindfulness (groups exposed to mindfulness intervention) will improve wellbeing in the infertile patient and her partner and that trait mindfulness will predict ability to become pregnant.
Study Overview
Status
Conditions
Detailed Description
Couples who have been trying to conceive for at least a year, have attended at least one doctor's appointment with an infertility/fertility specialist and have been advised by their physician to undergo their first IVF cycle will be recruited for this study.
Participants (couples) will be randomly assigned (assignment determined immediately following recruitment by a member of our research team), if eligible to one of four of five experimental conditions, which are described below. Assignment will occur on a 1:2:2:2:1 basis, such that for every two couples assigned to Conditions 2, 3 and 4 (mindfulness conditions) one couple will be assigned to Conditions 1 and 5 (control conditions). Couples will be told that we are interested in exploring if practicing mindful attention during the IVF process may improve patient and partner wellbeing during and following their first IVF cycle. All participants will be instructed to complete study measures, at three different points in time, via an online link.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karyn Gunnet-Shoval, PhD
- Phone Number: 6463301036
- Email: gunnetshoval@fas.harvard.edu
Study Contact Backup
- Name: Katherine Bercovitz
- Email: kbercovitz@g.harvard.edu
Study Locations
-
-
Massachusetts
-
Waltham, Massachusetts, United States, 02451
- Recruiting
- Boston IVF/IVF New England
-
Contact:
- Alice Domar, PhD
-
Principal Investigator:
- Karyn Gunnet-Shoval, PhD
-
Sub-Investigator:
- Katherine Bercovitz
-
Sub-Investigator:
- Ellen Langer, PhD
-
Sub-Investigator:
- Alice Domar, PhD
-
Sub-Investigator:
- Kristin Rooney
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria (infertile patients and their partners):
- 18+ years of age;
- Female patients who have been trying to conceive for at least a year, have attended at least one doctor's appointment with an infertility/fertility specialist and have been advised by their physician to undergo their first IVF cycle;
- Participants (patients and partners) with no known biological children.
Exclusion criteria (infertile patients and their partners):
- Individuals who do not meet the inclusion criteria above;
- Participants (patients and partners) with secondary infertility (already have a child);
- Participants (patients and partners) with a cut point score of less than 60 on the Mental Health Inventory (MHI-5) (assessed at phone screening).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Waitlist Control
All participants in this condition will complete all measures online at three different points in time, including one narrative response at T2.
|
|
Experimental: Attention to Variability - Patient Only
All participants in this condition will complete all measures online at three different points in time, including one narrative response at T2.
They will also be instructed to complete a mindfulness intervention at home and respond to diary-type text messaging questions twice daily for two weeks (14 days).
|
In Attention to Variability we ask the participant to attend to the natural fluctuations in mood and physiology that occur throughout the day, to notice when a symptom is better or worse and to ask why it may be.
|
Experimental: Attention to Variability - Partner Only
All participants in this condition will complete all measures online at three different points in time, including one narrative response at T2.
Partners of the infertile women will also be instructed to complete a mindfulness intervention at home and respond to diary-type text messaging questions twice daily for two weeks (14 days).
|
In Attention to Variability we ask the participant to attend to the natural fluctuations in mood and physiology in their partner that occur throughout the day, to notice when a symptom is better or worse and to ask why it may be.
|
Experimental: Attention to Variability - Patient & Partner
All participants in this condition will complete all measures online at three different points in time, including one narrative response at T2.
All participants (patients and partners) will also be instructed to complete a mindfulness intervention at home and respond to diary-type text messaging questions twice daily for two weeks (14 days).
|
Same as patient and partner only conditions, just that in this condition both the patient and partner do their corresponding intervention rather than only one of them.
|
Active Comparator: Infertility Stories - Reading
All participants in this condition will complete all measures online at three different points in time, including one narrative response at T2.
They will also be instructed to do an at-home reading activity several times over a period of 2 weeks.
|
Reading Stories About Others' Infertility Experiences
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient and Partner Wellbeing - Langer Mindfulness Scale (LMS)
Time Frame: Approximately 8 minutes
|
4 subscales, each ranging from 1-7, with 1 being 'Strongly Disagree' and 7 being 'Strongly Agree'.
Subscales are 'Flexibility' (includes 4 items); 'Novelty Seeking' (6 items); 'Novelty Producing' (6 items); 'Engagement' (5 items).
7 items are reverse scored.
To determine overall Mindfulness score, sum all items (items 1-21).
|
Approximately 8 minutes
|
Patient and Partner Wellbeing - Positive and Negative Affect Schedule (PANAS)
Time Frame: Approximately 8 minutes
|
Scale consists of a number of words that describe different feelings and emotions. Participants indicate to what extent they have a particular way in the past few hours. The scale ranges from 1 (Very slightly or not at all) to 5 (extremely). Individuals decide which of the 20 questions are positive and which are negative. Scores are then added for the 10 positive words and separately for the 10 negative words. The scores generated will vary along the scale of 10 - 50, with lower scores indicating low (positive or negative) affect and higher scores indicating high (positive or negative) affect. |
Approximately 8 minutes
|
Patient and Partner Wellbeing - Rosenberg Self-Esteem Scale (RSE)
Time Frame: Approximately 5 minutes
|
A 10-item scale that measures global self-worth by measuring both positive and negative feelings about the self. The scale is believed to be unidimensional. All items are answered using a 4-point Likert scale format ranging from 1 (strongly agree) to 4 (strongly disagree). Scoring: Items 2, 5, 6, 8, 9 are reverse scored. Scores are then summed for all ten items on a continuous scale. Higher scores indicate higher self-esteem. |
Approximately 5 minutes
|
Patient and Partner Wellbeing - Satisfaction With Life Scale (SWLS)
Time Frame: Approximately 3 minutes
|
A 5-item scale designed to measure global cognitive judgments of one's life satisfaction. Participants indicate how much they agree or disagree with each of the 5 items using a 7-point scale that ranges from 1 (strongly disagree) to 1 (strongly agree). Scoring : Scoring should be kept continuous (scores are summed up on each item). |
Approximately 3 minutes
|
Patient and Partner Wellbeing - Perceived Stress Scale (PSS)
Time Frame: Approximately 5 minutes
|
The following questions ask about one's feelings and thoughts during the past month. In each question, individuals are asked how often they felt or thought a certain way. Scoring: Each item is rated on a 5-point scale ranging from (0) never to (4) almost always. Positively worded items are reverse scored, and the ratings are summed, with higher scores indicating more perceived stress. PSS-10 scores are obtained by reversing the scores on the four positive items: For example, 0=4, 1=3, 2=2, etc. and then summing across all 10 items. Items 4, 5, 7, and 8 are the positively stated items. |
Approximately 5 minutes
|
Patient and Partner Wellbeing - Couples Satisfaction Index (CSI)
Time Frame: Approximately 11 minutes
|
A 32-item scale designed to measure one's satisfaction in a relationship. The scale has a variety of items with different response scales and formats. Question Scoring: 1: 0 (Extremely Unhappy) to 6 (Perfect); 2-4: 0 (Always Disagree) to 5 (Always Agree); 5: 0 (Never) to 5 (All the time); 6: 0 (All the time) to 5 (Never); 7-18: 0 (Not at all True) to 5 (Completely True); 19-22: 0 (Not at All) to 5 (Completely); 23: 0 (Worse than all others [extremely bad]) to 5 (Better than all others [extremely good]); 24-25: 0 (Never) - 5 (More Often); 26: 0 (Boring) to 5 (Interesting); 27: 0 (Bad) to 5 (Good); 28: 0 (Empty) to 5 (Full); 29: 0 (Lonely) to 5 (Friendly); 30: 0 (Fragile) to Sturdy (5); 31: 0 (Discouraging) to 5 (Hopeful); 32: 0 (Miserable) to 5 (Enjoyable). |
Approximately 11 minutes
|
Patient and Partner Wellbeing - Tolerance of Ambiguity Scale
Time Frame: Approximately 10 minutes
|
The instrument consists of 16 items on a scale ranging from 1 (Strongly Disagree) to 7 (Strongly Agree). High scores indicate a greater intolerance for ambiguity. To score the instrument, the even-numbered items must be reverse-scored. Three subscales can also be computed to reveal the major source of intolerance of ambiguity - novelty (N), complexity (c), or insolubility (I). Having intolerance of ambiguity means that an individual tends to perceive situations as threatening rather than promising. Lack of information or uncertainty, for example, would make such a person uncomfortable. Ambiguity arises from three main sources: novelty, complexity and insolubility. |
Approximately 10 minutes
|
Patient and Partner Wellbeing - Narrative question about their mind-body experience
Time Frame: Approximately 8 minutes
|
Narrative question about their mind-body experience over the past three weeks
|
Approximately 8 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Ability to become pregnant
Time Frame: 2 minutes
|
Question about whether or not they got pregnant
|
2 minutes
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karyn Gunnet-Shoval, PhD, Harvard University
- Study Director: Ellen Langer, PhD, Harvard University
- Principal Investigator: Katherine Bercovitz, Harvard University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB16-1683
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Istanbul University - Cerrahpasa (IUC)RecruitingInfertility | Sexual Dysfunction | Infertility, Male | Nurse's Role | Sexuality | Infertility; FemaleTurkey
Clinical Trials on Attention to Variability - Patient Only
-
Harvard UniversityWithdrawn
-
Tel Aviv UniversityCompletedAnxiety DisordersIsrael
-
VA Office of Research and DevelopmentCompleted
-
University of WashingtonCompletedImplantable Cardioverter Defibrillator (ICD)United States
-
Massachusetts General HospitalColorado State UniversityRecruitingSubstance Use DisordersUnited States
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Completed
-
Nantes University HospitalCompletedProton Pump Inhibitors | DeprescriptionFrance
-
University of PittsburghSuspended
-
University of Wisconsin, MadisonNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Duke... and other collaboratorsCompleted
-
University at BuffaloCompleted